Stone Disease of the Urinary Tract in Children
Launched by UNIVERSITY HOSPITAL, STRASBOURG, FRANCE · Sep 4, 2023
Trial Information
Current as of August 25, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on understanding stone disease in children, which is when small, hard deposits form in the urinary tract and can cause pain and other health issues. The researchers are looking into how common this condition is, how it varies among different groups of children, and the best ways to diagnose and treat it. They want to find out more about the different types of stones that can form and what might cause them, especially since children with certain health issues or younger age may be more likely to have them again.
To participate in the trial, children under 18 years old who have had urinary stones diagnosed between January 1, 2010, and December 31, 2022, can be included. Parents or guardians need to agree to share their child’s health information for this study. Participants can expect to help researchers gather important data that could improve how we understand and manage urinary stones in kids, which can ultimately lead to better treatment options in the future.
Gender
ALL
Eligibility criteria
- Inclusion criteria:
- • Patients aged less than 18 years.
- • Both sexes.
- • Subjects presenting with lithiasis of the urinary tree in one of the two departments concerned between 01/01/2010 and 12/31/2022
- • Subject not opposing, after information, the reuse of their data for the purposes of this research.
- • Holders of parental authority who do not object, after being informed, to the reuse of their child's data for the purposes of this research.
- Exclusion criteria:
- • Subject or holder of parental authority having expressed opposition to participating in the study.
- • Non-usable patient files: insufficient data.
About University Hospital, Strasbourg, France
The University Hospital of Strasbourg, France, is a leading academic medical center renowned for its commitment to advancing healthcare through innovative clinical research and patient-centered care. As a prominent sponsor of clinical trials, the institution collaborates with a diverse range of healthcare professionals and research teams to explore cutting-edge therapies and treatment modalities. With state-of-the-art facilities and a multidisciplinary approach, the University Hospital of Strasbourg plays a pivotal role in translating scientific discoveries into effective clinical applications, contributing significantly to the advancement of medical knowledge and improved patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Strasbourg, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported